Precursor-directed Biosynthesis of New Sansanmycin Analogs Bearing Para-substituted-phenylalanines with High Yields
Overview
Overview
Journal
J Antibiot (Tokyo)
Specialties
Infectious Diseases
Pharmacology
Pharmacology
Date
2016 Feb 25
PMID
26905760
Citations
2
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Expanding structural diversity of 5'-aminouridine moiety of sansanmycin via mutational biosynthesis.
Lu Y, Li Y, Fan J, Li X, Sun H, Wang L Front Bioeng Biotechnol. 2023; 11:1278601.
PMID: 38026887 PMC: 10643210. DOI: 10.3389/fbioe.2023.1278601.
Improving the N-terminal diversity of sansanmycin through mutasynthesis.
Shi Y, Jiang Z, Lei X, Zhang N, Cai Q, Li Q Microb Cell Fact. 2016; 15:77.
PMID: 27154005 PMC: 4858918. DOI: 10.1186/s12934-016-0471-1.
References
1.
Zhang W, Ostash B, Walsh C
. Identification of the biosynthetic gene cluster for the pacidamycin group of peptidyl nucleoside antibiotics. Proc Natl Acad Sci U S A. 2010; 107(39):16828-33.
PMC: 2947877.
DOI: 10.1073/pnas.1011557107.
View
2.
Gotoh N, Murata T, Ozaki T, Kimura T, Kondo A, Nishino T
. Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa. J Infect Chemother. 2003; 9(1):101-3.
DOI: 10.1007/s10156-002-0205-2.
View
3.
Xie Y, Xu H, Si S, Sun C, Chen R
. Sansanmycins B and C, new components of sansanmycins. J Antibiot (Tokyo). 2008; 61(4):237-40.
DOI: 10.1038/ja.2008.34.
View
4.
Chen R, Buko A, Whittern D, McAlpine J
. Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. II. Isolation and structural elucidation. J Antibiot (Tokyo). 1989; 42(4):512-20.
DOI: 10.7164/antibiotics.42.512.
View
5.
Xie Y, Chen R, Si S, Sun C, Xu H
. A new nucleosidyl-peptide antibiotic, sansanmycin. J Antibiot (Tokyo). 2007; 60(2):158-61.
DOI: 10.1038/ja.2007.16.
View